Cambridge Healthtech Institute’s 6th Annual
Oligonucleotide CMC & Regulatory Strategies
Enhancing Analytical and Manufacturing Methods and Accelerating Time to Market
March 13-14, 2024
Cambridge Healthtech Institute's conference on Oligonucleotide CMC & Regulatory Strategies brings together leading scientists and executives from top biotech and pharma companies to share insights on new developments in analytical characterization, CMC, manufacturing, and regulatory issues. This conference will provide an opportunity to discuss and collaborate on how to optimize product development processes and achieve commercial success.